Dipeptidyl peptidase-4 inhibitors versus sulfonylureas on the top of metformin in patients with diabetes and acute myocardial infarction.

Cardiovasc Diagn Ther · 2024 · PMC10904300 · PMID 38434553

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

showed a trend toward reduced incidence of CV outcomes in MET-treated patients contrasting with a trend for an increase in MACE in patients not receiving MET ( 38 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.